Correlation between Cumulative Methotrexate Dose, Metabolic Syndrome and Hepatic Fibrosis Detected by FibroScan in Rheumatoid Arthritis Patients

Background and Objectives: Methotrexate (MTX) is routinely prescribed for rheumatoid arthritis (RA) patients, but high cumulative doses may lead to hepatic fibrosis. Additionally, a high proportion of RA patients suffer from metabolic syndrome, which also increases the risk of hepatic fibrosis. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Lertnawapan, Ratchaya, Chonprasertsuk, Soonthorn, Siramolpiwat, Sith, Jatuworapruk, Kanon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302919/
https://www.ncbi.nlm.nih.gov/pubmed/37374233
http://dx.doi.org/10.3390/medicina59061029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302919/
https://www.ncbi.nlm.nih.gov/pubmed/37374233
http://dx.doi.org/10.3390/medicina59061029

Ejemplares similares